(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010Liz Krutoholow, Specialty Pharma and Biotech Analyst for Bloomberg Intelligence, on the statements in Valeant's annual report filed today.

Dick’s Projects Sales Growth at Namesake Stores, Foot Locker
14:01

Nvidia Invests $2 Billion in Nebius for New Data Center Deal
27:35

Ackman’s Pershing Square Seeks Up to $10 Billion in NYSE IPO
17:40